Markers of brain damage in full-term newborns with intrauterine growth retardation
- Authors: Evsyukova I.I.1
-
Affiliations:
- The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
- Issue: Vol 70, No 6 (2021)
- Pages: 83-90
- Section: Reviews
- URL: https://journals.rcsi.science/jowd/article/view/80115
- DOI: https://doi.org/10.17816/JOWD80115
- ID: 80115
Cite item
Abstract
The increase in the number of newborns with intrauterine growth retardation, who are characterized not only by high perinatal morbidity and mortality, but also by neurodevelopmental disorders in later life, has determined a wide search for diagnostic markers of prenatal hypoxia for a timely objective assessment of brain damage and a justification of neuroprotection methods. This article presents literature data on biomarkers and methods of instrumental diagnosis of brain damage that have received evidence of the effectiveness of their use in early neonatal life of newborns with intrauterine growth retardation. It is emphasized that such biomarkers as S100B, NSE, and BDNF proteins are the most reliable and easy to determine non-invasively. However, for their wide application in clinical practice, it is necessary to establish reference values in umbilical cord blood and urine, while taking into account the gestational age, sex, and method of giving birth, and to unify the use of laboratory analysis systems and diagnostic tests for this purpose. The comparison of biomarker indicators with cerebral oximetry, electroencephalogram and magnetic resonance imaging data will allow for developing new approaches to the treatment of perinatal pathology and, largely, preventing adverse consequences in those born with intrauterine growth retardation.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Inna I. Evsyukova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Author for correspondence.
Email: eevs@yandex.ru
ORCID iD: 0000-0003-4456-2198
SPIN-code: 4444-4567
MD, Dr. Sci. (Med.), Professor
Russian Federation, Saint PetersburgReferences
- Malhotra A, Allison BJ, Castillo-Melendez M, et al. Neonatal morbidities of fetal growth restriction: Pathophysiology and impact. Front Endocrinol (Lausanne). 2019;10:55. doi: 10.3389/fendo.2019.00055
- Wang Y, Fu W, Liu J. Neurodevelopment in children with intrauterine growth restriction: adverse effects and interventions. J Matern Fetal Neonatal Med. 2016;29(4):660−668. doi: 10.3109/14767058.2015.1015417
- Armengaud JB, Yzydorczyk C, Siddeek B, et al. Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reprod Toxicol. 2021;99:168−176. doi: 10.1016/j.reprotox.2020.10.005
- Dall’Asta A, Brunelli V, Prefumo F. Early onset fetal growth restriction. Matern Health Neonatol Perinatol. 2017;3:2. doi: 10.1186/s40748-016-0041-x
- Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr. 2016;10:67–83. doi: 10.4137/CMPed.S40070
- Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J Physiol. 2016;594(4):807–823. doi: 10.1113/JP271402
- Hartkopf J, Schleger F, Keune J, et al. Impact of intrauterine growth restriction on cognitive and motor development at 2 years of age. Front Physiol. 2018;9:1278. doi: 10.3389/fphys.2018.01278
- Sacchi C, Marino C, Nosarti C, et al. Association of intrauterine growth restriction and small for gestational age status with childhood cognitive outcomes: A systematic review and meta-analysis. JAMA Pediatr. 2020;174(8):772−781. doi: 10.1001/jamapediatrics.2020.1097
- Korkalainen N, Partanen L, Rasanen L, et al. Fetal hemodynamics and language skills in primary school-aged children with fetal growth restriction: A longitudinal study. Early Hum Dev. 2019;134:34−40. doi: 10.1016/j.earlhumdev.2019.05.019
- Pels A, Knaven OC, Wijnberg-Williams BJ, et al. Neurodevelopmental outcomes at five years after early-onset fetal growth restriction: Analyses in a Dutch subgroup participating in a European management trial. Eur J Obstet Gynecol Reprod Biol. 2019;234:63−70. doi: 10.1016/j.ejogrb.2018.12.041
- Vollmer B, Edmonds CJ. School age neurological and cognitive outcomes of fetal growth retardation or small for gestational age birth weight. Front Endocrinol (Lausanne). 2019;10:186. doi: 10.3389/fendo.2019.00186
- Arcangelli T, Thilaganathan B, Hooper R, et al. Neurodevelopmental delay in small babies at term: a systematic review. Ultrasound Obstet Gynecol. 2012;40(3):267−275. doi: 10.1002/uog.11112.
- Batalle D, Munoz-Moreno E, Arbat-Plana A. Long-term reorganization of structural brain networks in a rabbit model of intrauterine growth restriction. Neuroimage. 2014;100:24−38. doi: 10.1016/j.neuroimage.2014.05.065
- Hsiao EY, Patterson PH. Placental regulation of maternal-fetal interactions and brain development. Dev Neurobiol. 2012;72(10):1317−1326. doi: 10.1002/dneu.22045
- Lemasters JJ, QianT, He L, et al. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal. 2002;4(5):769−781. doi: 10.1089/152308602760598918
- Solevåg AL, Schmölzer GM, Cheung PY. Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia. Free Radic Biol Med. 2019;142:113–122. doi: 10.1016/j.freeradbiomed.2019.04.028
- Kaur C, Rathnasamy G, Ling EA. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J Neuroimmune Pharmacol. 2013;8(1):66–78. doi: 10.1007/s11481-012-9347-2
- Maltepe E, Bakardjiev AI, Fisher SJ. The placenta: transcriptional? Epigenetic? And physiological integration during development. J Clin Invest. 2010;120(4):1016−1125. doi: 10.1172/JCI41211
- Jawahar MC, Murgatroyd C, Harrison EL, Baune BT. Epigenetic alterations following early postnatal stress: a review on novel aetiological mechanisms of common psychiatric disorders. Clin Epigenetics. 2015;7:122. doi: 10.1186/s13148-015-0156-3
- Bale TL, Baram TZ, Brown AS, et al. Early life programming and neurodevelopmental disorders. Biol Psychiatry. 2010;68(4):314−319. doi: 10.1016/j.biopsych.2010.05.028
- Perrone S, Santacroce A, Picardi A, Buonocore G. Fetal programing and early identification of newborns at risk of free radical-mediated diseases. World J Clin Pediatr. 2016;5(2):172−181. doi: 10.5409/wjcp.v5.i2.172
- Bos AF, Einspieler C, Prechtl HF. Intrauterine growth retardation, general movements, and neurodevelopmental outcome: a review. Dev Med Child Neurol. 2001;43(1):61−68. doi: 10.1017/s001216220100010x
- Zuk L, Harel S, Leitner Y, Fattal-Valevski A. Neonatal general movements: an early predictor for neurodevelopmental outcome in infants with intrauterine growth retardation. J Child Neurol. 2004;19(1):14−18. doi: 10.1177/088307380401900103011
- Bersani I, Pluchinotta F, Dotta A, et al. Early predictors of perinatal brain damage: the role of neurobiomarkers. Clin Chem Lab Med. 2020;58(4):471–486. doi: 10.1515/cclm-2019-0725
- Negro S, Benders MJNL, Tataranno ML, et al. Early prediction of hypoxic-ischemic brain injury by a new panel of biomarkers in a population of term newborns. Oxid Med Cell Longev. 2018;2018:7608108. doi: 10.1155/2018/7608108
- Longini M, Belvisi E, Proietti F, et al. Oxidative stress biomarkers: Establishment of reference values for isoprostanes, AOPP, and NPBI in cord blood. Mediators Inflam. 2017;2017:1758432. doi: 10.1155/2017/1758432
- Casetta B, Longini M, Proietti F, et al. Development of a fast and simple LC-MS/ MS method for measuring the F2-isoprostanes in newborns. J Matern Fetal Neonat Med. 2012;25(1):114−118. doi: 10.3109/14767058.2012.664856
- Paffetti P, Perrone S., Longini M, et al. Non-protein-bound iron detection in small samples of biological fluids and tissues. Biol Trace Elem Res. 2006;112(3):221–232. doi: 10.1385/BTER:112:3:221
- Perrone S, Laschi E, Buonocore G. Oxidative stress biomarkers in the perinatal period: Diagnostic and prognostic value. Sem Fetal Neonatal Med. 2020;25(2):101087. doi: 10.1016/j.siny.2020.101087
- Lu H, Huang W, Chen X, et al. Relationship between premature brain injury and multiple biomarkers in cord blood and amniotic fluid. J Matern-Fetal Neonatal Med. 2018;31(21):2898–2904. doi: 10.1080/14767058.2017.1359532
- Gazzolo D, Marinoni E, di Iorio R, et al. Circulating S100beta protein is increased in intrauterine growth-retarded fetuses. Pediatr Res. 2002;51(2):215–219. doi: 10.1203/00006450-200202000-00015
- Gazzolo D, Frigiola A, Bashir M, et al. Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. PLoS One. 2009;4(2):e4298. doi: 10.1371/journal.pone.0004298
- Florio P, Marinoni E, Di Iorio R, et al. Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics. 2006;118(3):e747–754. doi: 10.1542/peds.2005-2875
- Roka A, Kelen D, Halasz J, et al. Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr. 2012;101(3):319–323. doi: 10.1111/j.1651-2227.2011.02480.x
- Nagdyman N, Komen W, Ko H, et al. Early biochemical indicators of hypoxic ischemic encephalopathy after birth asphyxia. Pediatr Res. 2001;49(4):502–506. doi: 10.1203/00006450-200104000-00011
- Costantine MM, Weiner SJ, Rouse DJ, et al. Umbilical cord blood biomarkers of neurologic injury and the risk of cerebral palsy or infant death. Int J Dev Neurosci. 2011;29(8):917–922. doi: 10.1016/j.ijdevneu.2011.06.009
- Celtik C, Acunaş B, Oner N, Pala O. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev. 2004;26(6):398–402. doi: 10.1016/j.braindev.2003.12.007
- Mazarico E, Llurba E, Cabero L, et al. Associations between neural injury markers of intrauterine growth-restricted infants and neurodevelopment at 2 years of age. J Matern Fetal Neonatal Med. 2019;32(19):3197−3203. doi: 10.1080/14767058.2018.1460347
- Kolevzon A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med. 2007;161(4):326−333. doi: 10.1001/archpedi.161.4.326
- Eide MG, Moster D, Irgens LM, et al. Degree of fetal growth restriction associated with schizophrenia risk in a national cohort. Psychol Med. 2013;43(10):2057−2066. doi: 10.1017/S003329171200267X
- Giannopoulou I, Pagida MA, Briana DD, Panayotacopoulou MT. Perinatal hypoxia as a risk factor for psychopathology later in life: the role of dopamine and neurotrophins. Hormones (Athens). 2018;17(1):25−32. doi: 10.1007/s42000-018-0007-7
- Homberg JR, Molteni R, Calabrese F, Riva MA. The serotonin-bdnf duo: developmental implications for the vulnerability to psychopathology. Neurosci Biobehav Rev. 2014;43:35−47. doi: 10.1016/j.neubiorev.2014.03.012
- Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev. 2012;64(2):238−258. doi: 10.1124/pr.111.005108
- Malamitsi-Puchner A, Nikolaou KE, Economou E, et al. Intrauterine growth restriction and circulating neurotrophin levels at term. Early Hum Dev. 2007;83(7):465−469. doi: 10.1016/j.earlhumdev.2006.09.001
- Cannon TD, Yolken R, Buka S, Torrey EF. Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol Psychiatry. 2008;64(9):797−802. doi: 10.1016/j.biopsych.2008.04.012
- Briana DD, Malamitsi-Puchner A. Perinatal biomarkers implying ‘Developmental Origins of Health and Disease’ consequences in intrauterine growth restriction. Acta Paediatr. 2020;109(7):1317−1322. doi: 10.1111/apa.15022
- Morozova AYu, Milyutina YuP, Kovalchuk-Kovalevskaya OV, et al. Neuron-specific enolase and brain-derived neurotrophic factor levels in umbilical cord blood in full-term newborns with intrauterine growth retardation. Journal of Obstetrics and Women’s Diseases. 2019;68(1):29−36. (In Russ.). doi: 10.17816/JOWD68129-36
- Boersma GJ, Lee RS, Cordner ZA, et al. Prenatal stress decreases Bdnf expression and increases methylation of Bdnfexon IV in rats. Epigenetics. 2014;9(3):437−447. doi: 10.4161/epi.27558
- Blinov DV. The diagnostic value of eeg and biochemical markers of brain injury in hypoxic-ischemic encephalopathy. Epilepsiya i paroksizmal’nye sostonyaniya. 2016;8(4):91−98. (In Russ.). doi: 10.17749/2077-8333.2016.8.4.091-098
- Melashenko TV, Pozdnyakov AV, Lvov VS, Ivanov DO. MR-patterns of brain’s hypoxic-ischemic lesions in term newborns. Pediatr. 2017;8(6):86–93. (In Russ.). doi: 10.17816/PED8686-93
- Evsyukova II, Kovalchuk-Kovalevskaya OV, Zvereva NA, et al. Cerebral oximetry as method of diagnostics of perinatal brain pathology in newborns with intrauterine growth retardation. Neonatologiya; novosti, mneniya, obuchenie. 2020;8(1):9−14. (In Russ.). doi: 10.33029/2308-2402-2020-8-1-9-14